Literature DB >> 27270565

Evaluation of cutaneous surface parameters in psoriatic patients.

S P Cannavò1, F Guarneri1, R Giuffrida1, E Aragona1, C Guarneri1.   

Abstract

PURPOSE: The purpose of this study was to compare cutaneous surface parameters in lesional and non-lesional skin of psoriatic patients and in corresponding areas of control subjects.
METHODS: Sixty-six psoriatic patients (of any grade of severity, with or without arthritis, without any therapy other than systemic biologic drugs) and 28 healthy controls were enrolled in this observational, case-control study. Exclusion criteria were current or past sebo-psoriasis and seborrheic dermatitis, pustular or erithrodermic psoriasis; treatment with immune-suppressive agents, retinoids, or ultraviolet phototherapy in the last 6 months; topical treatment in the last 2 weeks. Corneometry, sebumetry, and pHmetry were evaluated on non-lesional skin of forehead, cheek, chin and volar region of forearm, and on a psoriatic plaque (on elbow or neighboring areas); in controls, the same areas were considered.
RESULTS: Corneometry values were significantly lower in psoriatic plaques vs. elbows of controls. Sebumetry showed significantly higher values in non-lesional forearm skin and plaques of psoriatic patients vs. corresponding areas of controls. pH was significantly lower in all areas in psoriasis. No differences were found between patients treated or not with biologics and with or without arthritis.
CONCLUSION: Evaluating surface skin parameters in psoriasis is useful to better understand the etiopathogenic mechanism and could suggest new therapeutic approaches.
© 2016 John Wiley & Sons A/S. Published by John Wiley & Sons Ltd.

Entities:  

Keywords:  corneometry; cutaneous surface; pHmetry; psoriasis; sebumetry

Mesh:

Year:  2016        PMID: 27270565     DOI: 10.1111/srt.12299

Source DB:  PubMed          Journal:  Skin Res Technol        ISSN: 0909-752X            Impact factor:   2.365


  11 in total

1.  Phytoecdysteroids from Serratula coronata L. for Psoriatic Skincare.

Authors:  Anna Kroma; Mariola Pawlaczyk; Agnieszka Feliczak-Guzik; Maria Urbańska; Dorota Jenerowicz; Agnieszka Seraszek-Jaros; Małgorzata Kikowska; Justyna Gornowicz-Porowska
Journal:  Molecules       Date:  2022-05-27       Impact factor: 4.927

2.  Efficacy of Systemic Biologic Drugs in Pediatric Psoriasis: Evidence From Five Selected Randomized Clinical Trials.

Authors:  Vito Di Lernia; Laura Macca; Lucia Peterle; Ylenia Ingrasciotta; Gianluca Trifirò; Claudio Guarneri
Journal:  Front Pharmacol       Date:  2022-04-05       Impact factor: 5.988

3.  Pre-digest of unprotected DNA by Benzonase improves the representation of living skin bacteria and efficiently depletes host DNA.

Authors:  Yacine Amar; Ilias Lagkouvardos; Rafaela L Silva; Oluwaseun Ayodeji Ishola; Bärbel U Foesel; Susanne Kublik; Anne Schöler; Sebastian Niedermeier; Rachela Bleuel; Alexander Zink; Klaus Neuhaus; Michael Schloter; Tilo Biedermann; Martin Köberle
Journal:  Microbiome       Date:  2021-05-26       Impact factor: 14.650

4.  Topical and transdermal delivery with diseased human skin: passive and iontophoretic delivery of hydrocortisone into psoriatic and eczematous skin.

Authors:  Behnam Dasht Bozorg; Sonalika A Bhattaccharjee; Mahadevabharath R Somayaji; Ajay K Banga
Journal:  Drug Deliv Transl Res       Date:  2021-01-11       Impact factor: 5.671

5.  Microneedle and iontophoresis mediated delivery of methotrexate into and across healthy and psoriatic skin.

Authors:  Deepal Vora; Harsha T Garimella; Carrie L German; Ajay K Banga
Journal:  Int J Pharm       Date:  2022-03-21       Impact factor: 6.510

6.  Skin Barrier Function in Psoriasis and Atopic Dermatitis: Transepidermal Water Loss and Temperature as Useful Tools to Assess Disease Severity.

Authors:  Trinidad Montero-Vilchez; María-Victoria Segura-Fernández-Nogueras; Isabel Pérez-Rodríguez; Miguel Soler-Gongora; Antonio Martinez-Lopez; Ana Fernández-González; Alejandro Molina-Leyva; Salvador Arias-Santiago
Journal:  J Clin Med       Date:  2021-01-19       Impact factor: 4.241

Review 7.  Mutual Influence of Psoriasis and Sport.

Authors:  Paolo Custurone; Laura Macca; Lucrezia Bertino; Debora Di Mauro; Fabio Trimarchi; Mario Vaccaro; Francesco Borgia
Journal:  Medicina (Kaunas)       Date:  2021-02-10       Impact factor: 2.430

8.  Cost-utility and budget impact analysis of adding-on apremilast to biologic therapy in the treatment of moderate to severe plaque psoriasis, an Iranian payer perspective.

Authors:  Marzieh Zargaran; Fatemeh Soleymani; Saman Ahmad Nasrollahi; Meysam Seyedifar; Mohammad Mehdi Ashrafian Rahaghi
Journal:  Res Pharm Sci       Date:  2021-06-30

Review 9.  Novel Therapeutic Approaches to Psoriasis and Risk of Infectious Disease.

Authors:  Alfonso Motolese; Manuela Ceccarelli; Laura Macca; Federica Li Pomi; Ylenia Ingrasciotta; Giuseppe Nunnari; Claudio Guarneri
Journal:  Biomedicines       Date:  2022-01-21

10.  Epidermal Barrier Function and Skin Homeostasis in Atopic Dermatitis: The Impact of Age.

Authors:  Trinidad Montero-Vilchez; Carlos Cuenca-Barrales; Juan-Angel Rodriguez-Pozo; Pablo Diaz-Calvillo; Jesús Tercedor-Sanchez; Antonio Martinez-Lopez; Alejandro Molina-Leyva; Salvador Arias-Santiago
Journal:  Life (Basel)       Date:  2022-01-17
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.